Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Business Wire
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending December 31, 2024.First Quarter 2024 Highlights Compared to First Quarter 2023:Worldwide GAAP sales increased 13 percent to $191.7 million; worldwide non-GAAP sales increased 12 percent to $192.8 million.Worldwide pump shipments increased 9 percent to approximately 25,000 pumps from 23,000 pumps.First quarter 2024 commercial launches:Launched Tandem Mobi with Dexcom G6 continuous glucose monitoring (CGM) sensor integration in the United States.Launched t:slim X2 integration with the Abbott Freestyle Libre 2 Plus CGM sensor in the United States.Initiated rolling launch of t:slim X2 with Dexcom G7 sensor integration outside the United States.Received U.S. Food and Drug Administration clearance to expand the Tandem Mobi pump indication
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- FDA issues 'most serious type of recall' for insulin pump-related iOS app [FOX Business Network]FOX Business Network
- Faulty insulin pump tech led to hundreds of injuries, prompting app ecall [CBS News]CBS News
- FDA recalls defective iOS app that injured over 200 insulin pump users [Verge, The]Verge, The
- $375+ Billion Drug Delivery Devices Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 and 2024-2029F [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $39.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
TNDM
Earnings
- 5/2/24 - Beat
TNDM
Sec Filings
- 5/16/24 - Form 8-K
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- TNDM's page on the SEC website